Matches in Nanopublications for { ?s ?p "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 28 of
28
with 100 items per page.
- NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_provenance.
- NP808980.RAaLcMrkr4KMUebp92cMXc0wd02Ljj934Fi_bUvdntan0130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808980.RAaLcMrkr4KMUebp92cMXc0wd02Ljj934Fi_bUvdntan0130_provenance.
- NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_provenance.
- NP974511.RA_X8zDvg3zv571Bn29vibXxEi2GVRX0zXj_S1xrGgx6E130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974511.RA_X8zDvg3zv571Bn29vibXxEi2GVRX0zXj_S1xrGgx6E130_provenance.
- NP904803.RA5KKyjHOpca-igIznC7N06b5rsa0szL4Kb9ZvdcdNUy8130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904803.RA5KKyjHOpca-igIznC7N06b5rsa0szL4Kb9ZvdcdNUy8130_provenance.
- NP904814.RA2YirlI8EaEdvx2DqitQnFX7Inixa4OHpN6iS3lCvL9g130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904814.RA2YirlI8EaEdvx2DqitQnFX7Inixa4OHpN6iS3lCvL9g130_provenance.
- NP904816.RAxUasiN0ohLpr3R3VNKioY5WPTVFwbgIud_9NkyaIs2w130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904816.RAxUasiN0ohLpr3R3VNKioY5WPTVFwbgIud_9NkyaIs2w130_provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP974544.RAnWBtbBJvqmJSbobVKHE5fx5GXmPAoDrGi_9ZnS5rbug130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974544.RAnWBtbBJvqmJSbobVKHE5fx5GXmPAoDrGi_9ZnS5rbug130_provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP644967.RAodJ02AaSnUhqj1YGZoW7zKgXeuplygZK9dAEz8MARfo130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644967.RAodJ02AaSnUhqj1YGZoW7zKgXeuplygZK9dAEz8MARfo130_provenance.
- NP943837.RAG5PUDiVR0y0GfhFGQNDky7qsMuSy_5SearnZNcFAjdM130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943837.RAG5PUDiVR0y0GfhFGQNDky7qsMuSy_5SearnZNcFAjdM130_provenance.
- NP904806.RAFCYZSYJCHH5qzmguhAaTQ-8sIcRY0pSgag5axFIAVeg130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904806.RAFCYZSYJCHH5qzmguhAaTQ-8sIcRY0pSgag5axFIAVeg130_provenance.
- NP904813.RAGZTQgrXZe_V3RSgttLI9sR8-rtrRSiP2oJynmNWYkV0130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904813.RAGZTQgrXZe_V3RSgttLI9sR8-rtrRSiP2oJynmNWYkV0130_provenance.
- NP943803.RAufvsiMUJvHz4mKVfQlM358EA33XZh7SJlbMyXTNyXHA130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943803.RAufvsiMUJvHz4mKVfQlM358EA33XZh7SJlbMyXTNyXHA130_provenance.
- NP904804.RAn54lWdoMp0ihmNnGPusFBcEUtacpMXl1dMl1lURPvhI130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904804.RAn54lWdoMp0ihmNnGPusFBcEUtacpMXl1dMl1lURPvhI130_provenance.
- NP904809.RAt8KSU2Wcf9s_6EgWOF_AOoOBOoMbYtHPAM52shDwftw130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904809.RAt8KSU2Wcf9s_6EgWOF_AOoOBOoMbYtHPAM52shDwftw130_provenance.
- NP904812.RAkd4Iz_IztoQIO08a5dBL0FgXINlKL8uL4OWGGAhTwo4130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904812.RAkd4Iz_IztoQIO08a5dBL0FgXINlKL8uL4OWGGAhTwo4130_provenance.